A Long-term Extension Study of PCI-32765 (Ibrutinib)

ClinicalTrials.gov ID: NCT01804686

Public ClinicalTrials.gov record NCT01804686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 9, 2026, 1:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

Study identification

NCT ID: NCT01804686
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 700 participants

Conditions and interventions

Conditions

Interventions

Ibrutinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 8, 2013
Primary completion: Dec 30, 2026
Completion: Aug 30, 2027
Last update posted: May 7, 2026

2013 – 2027

United States locations

U.S. sites: 32
U.S. states: 23
U.S. cities: 30

Facility	City	State	ZIP	Site status
City of Hope Cancer Center	Duarte	California	91010	Completed
University of California San Diego Medical Center	La Jolla	California	92093	Completed
University of California Los Angeles	Los Angeles	California	90095	Completed
St. Joseph Hospital Center for Cancer Prevention and Treatment	Orange	California	92868	Recruiting
Stanford University Medical Center	Stanford	California	94305	Completed
Stanford University	Stanford	California	94305	Completed
Norwalk Medical Group	Norwalk	Connecticut	06850	Completed
Northwest Georgia Oncology Centers PC	Marietta	Georgia	30060	Completed
Northwestern University Hospital	Chicago	Illinois	60611	Completed
Indiana University	Goshen	Indiana	46526	Completed
Kansas University Medical Center	Westwood	Kansas	66205	Completed
Louisville Oncology Suburban - Norton Cancer Institute	Louisville	Kentucky	40207	Completed
Dana Farber Cancer Center	Boston	Massachusetts	02215	Completed
University of Michigan Comprehensive Cancer Center	Ann Arbor	Michigan	48109	Completed
Battle Creek Health Systm	Battle Creek	Michigan	49016	Completed
Karmanos Cancer Institute - Wayne State University	Detroit	Michigan	48201	Completed
Washington University	St Louis	Missouri	63110	Completed
Dartmouth Hitchcock Medical Center	Lebanon	New Hampshire	03756	Completed
Hackensack University Medical Center	Hackensack	New Jersey	07601	Completed
Weill Medical College of Cornell University	New York	New York	10021	Completed
Memorial Sloan-Kettering Cancer Center	New York	New York	10065	Completed
Southeastern Medical Oncology Center	Goldsboro	North Carolina	27534	Completed
The Ohio State University- James Cancer Hospital	Columbus	Ohio	43210	Recruiting
Willamette Valley Cancer Center	Eugene	Oregon	97401	Recruiting
Kaiser Permanente	Portland	Oregon	97227	Completed
University of Pennsylvania Medical Center	Philadelphia	Pennsylvania	19104	Completed
Avera Medical Group	Sioux Falls	South Dakota	57105	Recruiting
MD Anderson Cancer Center - University of Texas	Houston	Texas	77030	Completed
University of Virginia	Charlottesville	Virginia	22908	Completed
University of Washington	Seattle	Washington	98109	Completed
West Virginia University	Morgantown	West Virginia	26506	Completed
University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research	Madison	Wisconsin	53705	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 143 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01804686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 9, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01804686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →